Bio-Rad Laboratories (BIO) Operating Margin (2016 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Operating Margin for 17 consecutive years, with 17.15% as the latest value for Q4 2025.
- On a quarterly basis, Operating Margin fell 2589.0% to 17.15% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.83%, a 865.0% decrease, with the full-year FY2025 number at 1.83%, down 865.0% from a year prior.
- Operating Margin was 17.15% for Q4 2025 at Bio-Rad Laboratories, down from 10.0% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 20.99% in Q3 2021 to a low of 17.15% in Q4 2025.
- A 5-year average of 11.96% and a median of 13.89% in 2022 define the central range for Operating Margin.
- Peak YoY movement for Operating Margin: surged 779bps in 2021, then plummeted -2589bps in 2025.
- Bio-Rad Laboratories' Operating Margin stood at 16.09% in 2021, then rose by 7bps to 17.28% in 2022, then decreased by -19bps to 13.99% in 2023, then tumbled by -38bps to 8.74% in 2024, then plummeted by -296bps to 17.15% in 2025.
- Per Business Quant, the three most recent readings for BIO's Operating Margin are 17.15% (Q4 2025), 10.0% (Q3 2025), and 11.83% (Q2 2025).